Articles

PROMETHEUS, prasugrel, clopidogrel, heart disease, bleeding, SCAI

Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneous coronary intervention (PCI) compared to clopidogrel, according to a new study. Results...

Cath lab

Most community hospitals with cardiac catheterization labs share these facilities with multiple, non-interventional cardiology users, which can be challenging to manage various specialties’ needs...

RaySafe i2 real-time dose monitoring, radiation dose monitoring, cath lab

Physicians and staff working in cath labs are constantly exposed to direct X-ray beams and scatter radiation. Traditionally cath lab staff wear radiation badges to record exposure, but these only...

heart stent, OAP therapy, ACS, patients, PCNA, SCAI, medication, prescribed

People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet (OAP) therapy and aspirin to help prevent a heart...

Medtronic, SYMPLICITY AF, PVI, renal denervation, Arctic Front, Spyral, G3

Medtronic plc announced the start of a clinical study to determine whether paroxysmal and persistent atrial fibrillation (AF) can be treated with a combination of two ablation procedures targeting...

therapeutic hypothermia, children, cardiac arrest, treatment, temperature

A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than...

radiation dose monitoring, cath lab dose monitoring, Raysafe

It’s the invisible elephant in radiology — radiation exposure. As physicians, we know all too well that exposure to radiation should be limited to the least amount possible. We have all learned...

Watchman, LAA, left atrial appendage

The long awaited U.S. Food and Drug Administration (FDA) approval of the first transcatheter left atrial appendage (LAA) occluder in March is seen by many cardiologists as a disruptive technology...

3D printing, 3-D printing

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015...

The Medicines Company, cangrelor, FDA advisory committee, approval

The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one abstention to recommend approval of...